Tomivosertib Uses, Dosage, Side Effects and more
Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).
| Trade Name | Tomivosertib |
| Generic | Tomivosertib |
| Tomivosertib Other Names | Tomivosertib |
| Type | |
| Formula | C17H20N6O2 |
| Weight | Average: 340.387 Monoisotopic: 340.164773908 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
